Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782.

@article{2019PreventionOG,
  title={Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782.},
  author={},
  journal={Obstetrics and gynecology},
  year={2019},
  volume={134 1},
  pages={
          e19-e40
        }
}
  • Published 2019
  • Medicine
  • Obstetrics and gynecology
  • Group B streptococcus (GBS) is the leading cause of newborn infection. The primary risk factor for neonatal GBS early-onset disease (EOD) is maternal colonization of the genitourinary and gastrointestinal tracts. Approximately 50% of women who are colonized with GBS will transmit the bacteria to their newborns. Vertical transmission usually occurs during labor or after rupture of membranes. In the absence of intrapartum antibiotic prophylaxis, 1-2% of those newborns will develop GBS EOD. Other… CONTINUE READING
    5 Citations

    References

    SHOWING 1-10 OF 142 REFERENCES
    Perinatal infections due to group B streptococci.
    • 164
    Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses
    • N. Russell, A. Seale, +14 authors C. Baker
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2017
    • 44
    • PDF
    Early-Onset Group B Streptococcal Disease in the United States: Potential for Further Reduction
    • 42
    Neonatal Group B Streptococcus Infections: Prevention Strategies, Clinical and Microbiologic Characteristics in 7 Years of Surveillance
    • 17
    Duration of Intrapartum Antibiotics for Group B Streptococcus on the Diagnosis of Clinical Neonatal Sepsis
    • 31
    • PDF
    Prevention of Perinatal Group B Streptococcal Disease
    • 437
    • PDF